Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

The Nonsynonymous-Single-Nucleotide Polymorphism (ns-SNP) 353 R>q in the Coagulation Factor VII (FVII) Gene, F7 , is Associated with Decreased Plasma FVII Levels and a Decreased Risk of Coronary Heart Disease (CHD) in Mexican Americans of South Texas

Kanisha Patel, Vincent P. Diego, Alberto D. Lopez, Marcio A. Almeida, Joanne E. Curran, Miguel Escobar, Jerry S. Powell, Donna M. Lehman, Ralph A DeFronzo, Sarah Williams-Blangero, Ravi Duggirala, Laura Almasy, John Blangero, Tom E. Howard

Blood (2022) 140 (Supplement 1): 2799–2800.

https://doi.org/10.1182/blood-2022-168478

Published: 2022

Journal Articles

BAX 335 Hemophilia B Gene Therapy Phase 1/2 Clinical Trial: Long-Term Safety and Efficacy Follow-up

Miguel Escobar, Barbara Konkle, Jonathan Ducore, Kavitha Rajavel, Kefeng Sun, Brian Yan, John Chapin

Blood (2022) 140 (Supplement 1): 10656–10657.

https://doi.org/10.1182/blood-2022-163297

Published: 2022

Journal Articles

Eptacog Beta Efficacy in Treating Mild or Moderate Bleeds in Target Joints of Individuals with Hemophilia A or B and Inhibitors in PERSEPT 1

Blood (2022) 140 (Supplement 1): 5597–5599.

https://doi.org/10.1182/blood-2022-156110

Published: 2022

Journal Articles

Bleeding Phenotype Does Not Appear to Correlate with Factor VIII Levels or Genetic Mutation in an Exclusive Pediatric Cohort of Hemophilia a Carriers

Joanna Larson, Katherine Addy, Deborah L. Brown, Nidra Rodriguez, Neethu M Menon, Miguel Escobar, Lakshmi Srivaths

Blood (2022) 140 (Supplement 1): 8458–8459.

https://doi.org/10.1182/blood-2022-160230

Published: 2022

Journal Articles

Cardiovascular Disease Prevention in Persons with Hemophilia

Brandon Hardesty, Joel Bowen, Suman L Sood, Craig M. Kessler, Maissaa Janbain, Miguel Escobar, Doris V. Quon

Blood (2022) 140 (Supplement 1): 10777–10778.

https://doi.org/10.1182/blood-2022-163807

Published: 2022

Journal Articles

A Nonsynonymous-Single-Nucleotide Polymorphism (ns-SNP) in TFPI , the Gene Encoding Tissue Factor Pathway Inhibitor (TFPI), is Pleiotropically Associated with Increased Plasma TFPI Levels and a Decreased Risk of Type 2 Diabetes (T2D) in Mexican Americans of South Texas

Alberto D. Lopez, Vincent P. Diego, Kanisha Patel, Marcio A. Almeida, Joanne E. Curran, Miguel Escobar, Jerry S. Powell, Donna M. Lehman, Ralph A DeFronzo, Sarah Williams-Blangero, Ravi Duggirala, Laura Almasy, John Blangero, Tom E. Howard

Blood (2022) 140 (Supplement 1): 8536–8537.

https://doi.org/10.1182/blood-2022-171201

Published: 2022

Journal Articles

A Preliminary Analysis of Athn 16: Safety of Coagulation Factor VIIa (recombinant)-Jncw for the Treatment of Bleeding Events in Patients with Congenital Hemophilia a or B with Inhibitors

Tammuella Chrisentery-Singleton, Lauren E. Amos, Daniel Bonzo, Miguel Escobar, Adam Giermasz, Emmanuelle Lagrue, Christine Knoll, Sonia Nasr, Michael Recht, Spencer Sullivan, Doris V. Quon, Mark T. Reding

Blood (2022) 140 (Supplement 1): 11360–11361.

https://doi.org/10.1182/blood-2022-163372

Published: 2022

Journal Articles

Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results

Frank W. G. Leebeek, Flora Peyvandi, Miguel Escobar, Andreas Tiede, Giancarlo Castaman, Michael Wang, Tung Wynn, Jovanna Baptista, Yi Wang, Jingmei Zhang, Björn Mellgård, Gülden Özen

Blood (2022) 140 (2): 89–98.

https://doi.org/10.1182/blood.2021014810

Published: 2022

Includes: Supplemental data

Journal Articles

Safety and Efficacy of Recombinant Factor VIIa (rFVIIa) in Congenital Hemophilia with Inhibitors (CHwI) in the Home Treatment Setting: Systematic Review of Clinical Studies and Registries

Guy Young, MD, Miguel Escobar, Steven Pipe, MD, David L. Cooper, MD MBA

Blood (2015) 126 (23): 2302.

https://doi.org/10.1182/blood.V126.23.2302.2302

Published: 2015

Journal Articles

Recombinant Factor VIIa Partially Reverses the Effects of Anticoagulants and Antiplatelet Agents on Thrombin Generation and Thromboelastography.

Mariam L. Abdullatif, Elizabeth Donnachie, PhD, Miguel Escobar, MD

Blood (2005) 106 (11): 4143.

https://doi.org/10.1182/blood.V106.11.4143.4143

Published: 2005

NARROW

The Nonsynonymous-Single-Nucleotide Polymorphism (ns-SNP) 353 R>q in the Coagulation Factor VII (FVII) Gene, F7 , is Associated with Decreased Plasma FVII Levels and a Decreased Risk of Coronary Heart Disease (CHD) in Mexican Americans of South Texas

BAX 335 Hemophilia B Gene Therapy Phase 1/2 Clinical Trial: Long-Term Safety and Efficacy Follow-up

Eptacog Beta Efficacy in Treating Mild or Moderate Bleeds in Target Joints of Individuals with Hemophilia A or B and Inhibitors in PERSEPT 1

Bleeding Phenotype Does Not Appear to Correlate with Factor VIII Levels or Genetic Mutation in an Exclusive Pediatric Cohort of Hemophilia a Carriers

Cardiovascular Disease Prevention in Persons with Hemophilia

A Nonsynonymous-Single-Nucleotide Polymorphism (ns-SNP) in TFPI , the Gene Encoding Tissue Factor Pathway Inhibitor (TFPI), is Pleiotropically Associated with Increased Plasma TFPI Levels and a Decreased Risk of Type 2 Diabetes (T2D) in Mexican Americans of South Texas

A Preliminary Analysis of Athn 16: Safety of Coagulation Factor VIIa (recombinant)-Jncw for the Treatment of Bleeding Events in Patients with Congenital Hemophilia a or B with Inhibitors

Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results

Safety and Efficacy of Recombinant Factor VIIa (rFVIIa) in Congenital Hemophilia with Inhibitors (CHwI) in the Home Treatment Setting: Systematic Review of Clinical Studies and Registries

Recombinant Factor VIIa Partially Reverses the Effects of Anticoagulants and Antiplatelet Agents on Thrombin Generation and Thromboelastography.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only